This analysis of the role of CerS-2 in PCC may lead to further understanding of the mechanism of development of PCC and may implicate the sphingolipid pathway as a possible novel therapeutic target for this rare tumor [49]. Here, CERS2 is linked to adrenal gland pheochromocytoma.